Ani Pharmaceuticals ANIP
NASDAQ ANIP
$67.79 +0.38 (+0.56%)
At close: Nov 9, 2026 · 4:00 PM EST

Ani Pharmaceuticals (ANIP) Total Non-Current Liabilities (2015 - 2026)

Updated

Ani Pharmaceuticals (ANIP) posted Total Non-Current Liabilities of $864.32 million for Q2 2026, down 0.5% from $868.86 million a year earlier but up 4.7% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Ani Pharmaceuticals' Total Non-Current Liabilities came in at $869.58 million, up 3.0% from FY2024.

  • Annual Total Non-Current Liabilities has increased for seven consecutive years, with a five-year compound annual growth rate of 28.2% (FY2020 to FY2025).
  • In prior years, Ani Pharmaceuticals' Total Non-Current Liabilities was $844.28 million in FY2024 (+95.8%), $431.15 million in FY2023 (+5.2%), $409.96 million in FY2022 (+2.8%) and $398.91 million in FY2021 (+58.9%).
  • Quarterly Total Non-Current Liabilities has run from a low of $270.94 million in Q3 2021 to a high of $871.69 million in Q3 2025 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities increased in six of the last eight quarters, with growth averaging 47.7%.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2025, with growth of 98.7%; the weakest was Q1 2026, with a decline of 1.5%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $825.37 million (Q1 2026), $869.58 million (Q4 2025) and $871.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 102.65 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 117.60 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 36.05 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 96.04 Bn
10 Ani Pharmaceuticals 1.43 Bn 212.92 Mn 165.89 Mn 864.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 864.32 Mn
Mar 31, 2026 825.37 Mn
Dec 31, 2025 869.58 Mn
Sep 30, 2025 871.69 Mn
Jun 30, 2025 868.86 Mn
Mar 31, 2025 837.66 Mn
Dec 31, 2024 844.28 Mn
Sep 30, 2024 841.51 Mn
Jun 30, 2024 437.32 Mn
Mar 31, 2024 434.75 Mn
Dec 31, 2023 431.15 Mn
Sep 30, 2023 444.23 Mn
Jun 30, 2023 432.96 Mn
Mar 31, 2023 436.13 Mn
Dec 31, 2022 409.96 Mn
Sep 30, 2022 392.36 Mn
Jun 30, 2022 407.26 Mn
Mar 31, 2022 390.69 Mn
Dec 31, 2021 398.91 Mn
Sep 30, 2021 270.94 Mn
API Access

Ani Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ANIP&period=max&api_key=YOUR_API_KEY